Evidence map›Paper›PMID 33741697›Full record

SynthesisDiabetes care2021

Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis.

Vasudha Ahuja, Pasi Aronen, T A Pramodkumar, Helen Looker, Angela Chetrit, Aini H Bloigu, Auni Juutilainen, Cristina Bianchi, Lucia La Sala, Ranjit Mohan Anjana and 23 more

Erratum issuedAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Prediabetes.Nature reviews. Disease primers · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Vasudha AhujaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland vasudha.ahuja@helsinki.fi.ORCID 0000-0002-6736-8809
Pasi AronenBiostatistics Unit, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
T A PramodkumarMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.
Helen LookerPhoenix Epidemiology and Clinical Research Branch, National Institute for Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
Angela ChetritUnit for Cardiovascular Epidemiology, Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan, Israel.
Aini H BloiguCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Auni JuutilainenUniversity of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Cristina BianchiSection of Diabetes and Metabolic Diseases, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Lucia La SalaDepartment of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy.ORCID 0000-0002-7580-1377
Ranjit Mohan AnjanaMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.ORCID 0000-0002-4843-1374
Rajendra PradeepaMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.
Ulagamadesan VenkatesanMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.
Sarvanan JebaraniMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.
Viswanathan BaskarMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.
Teresa Vanessa FiorentinoDepartment of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Patrick TimpelDepartment of Medicine III, Technical University of Dresden, Dresden, Germany.
Ralph A DeFronzoDivision of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.ORCID 0000-0002-8581-6273
Antonio CerielloDepartment of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy.ORCID 0000-0002-7955-4684
Stefano Del PratoSection of Diabetes and Metabolic Diseases, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.ORCID 0000-0002-5388-0270
Muhammad Abdul-GhaniDivision of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX.ORCID 0000-0003-4556-1787
Sirkka Keinänen-KiukaanniemiCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Rachel DanknerUnit for Cardiovascular Epidemiology, Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan, Israel.
Peter H BennettPhoenix Epidemiology and Clinical Research Branch, National Institute for Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
William C KnowlerPhoenix Epidemiology and Clinical Research Branch, National Institute for Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
Peter SchwarzDepartment of Medicine III, Technical University of Dresden, Dresden, Germany.
Giorgio SestiDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Rie OkaDepartment of Internal Medicine, Hokuriku Central Hospital, Toyama, Japan.
Viswanathan MohanMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, ICMR Centre for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes, Chennai, India.ORCID 0000-0001-5038-6210
Leif GroopInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Jaakko TuomilehtoPublic Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Samuli RipattiInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Michael BergmanDivision of Endocrinology and Metabolism, Department of Medicine and Department of Population Health, and NYU Langone Diabetes Prevention Program, NYU Grossman School of Medicine, New York, NY.ORCID 0000-0003-2589-2976
Tiinamaija TuomiInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-8306-6202

Funding

Epidemiology of Type 2 Diabetes Mellitus in the Gila River Indian CommunityZIADK069000 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KNOWLER, WILLIAM C · 2009 to 2021
$3.4M
6 · The paper itself

Abstract

objectiveOne-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accurate predictor of type 2 diabetes. We performed a meta-analysis to determine the optimum cutoff of 1-h PG for detection of type 2 diabetes using 2-h PG as the gold standard. RESEARCH DESIGN AND

methodsWe included 15 studies with 35,551 participants from multiple ethnic groups (53.8% Caucasian) and 2,705 newly detected cases of diabetes based on 2-h PG during OGTT. We excluded cases identified only by elevated fasting plasma glucose and/or HbA

resultsThree cutoffs of 1-h PG, at 10.6 mmol/L, 11.6 mmol/L, and 12.5 mmol/L, had sensitivities of 0.95, 0.92, and 0.87 and specificities of 0.86, 0.91, and 0.94 at weights 2/3, 1/2, and 1/3, respectively. The cutoff of 11.6 mmol/L (95% CI 10.6, 12.6) had a sensitivity of 0.92 (0.87, 0.95), specificity of 0.91 (0.88, 0.93), area under the curve 0.939 (95% confidence region for sensitivity at a given specificity: 0.904, 0.946), and a positive predictive value of 45%.

conclusionsThe 1-h PG of ≥11.6 mmol/L during OGTT has a good sensitivity and specificity for detecting type 2 diabetes. Prescreening with a diabetes-specific risk calculator to identify high-risk individuals is suggested to decrease the proportion of false-positive cases. Studies including other ethnic groups and assessing complication risk are warranted.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2AdultBlood GlucoseFastingGlucose Tolerance TestGlycated HemoglobinHumansSensitivity and SpecificityBlood GlucoseGlycated Hemoglobin

Identifiers

PMID33741697
PMCPMC8578930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.